Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells

Li,Bin; Li,Yu-Min; He,Wen-Ting; Chen,Hao; Zhu,Hong-Wen; Liu,Tao; Zhang,Jian-Hua; Song,Tie-Niu; Zhou,Ya-Li

doi:10.3892/or.2016.4803

Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells

Authors:
- Bin Li
- Yu-Min Li
- Wen-Ting He
- Hao Chen
- Hong-Wen Zhu
- Tao Liu
- Jian-Hua Zhang
- Tie-Niu Song
- Ya-Li Zhou
View Affiliations

Affiliations: Department of Thoracic Surgery, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, Lanzhou 730030, P.R. China, Department of General Surgery, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, Lanzhou 730030, P.R. China, Gansu Provincial Key Laboratory of Digestive System Tumors, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, Lanzhou 730030, P.R. China
Published online on: May 11, 2016 https://doi.org/10.3892/or.2016.4803
Pages: 223-230

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Esophageal squamous cell carcinoma (ESCC) is the most common type of esophageal carcinoma and remains the leading cause of cancer-related death worldwide. DEAD-box RNA helicases play critical roles in cellular metabolism and in many cases have been implicated in cellular proliferation and neoplastic transformation. DDX46 belongs to DEAD-box helicase family, the expression pattern of DDX46 in ESCC tissues and the biologic role in ESCC progression have not been implicated previously. In this study, DDX46 expression in human ESCC and adjacent normal tissues were explored using immunohistochemistry, and ESCC cell lines compared with normal esophageal epithelium cell were quantified using real‑time PCR. Next, lentivirus-mediated RNA interference was applied to silence DDX46 in TE-1 and Eca-109 cells. Cell growth was monitored using high content screening. Cell viability was measured by MTT assay. Cell colony-forming capacity was measured by colony formation assay. Cell cycle progression and apoptosis were determined by flow cytometry. Further, the stress and apoptosis signaling antibody array kit was used to detect the changes of signaling molecules in TE-1 cells after DDX46 knockdown. We found that DDX46 was significantly upregulated in ESCC tissues and cells compared with normal tissues and cells. DDX46 knockdown led to decreased proliferation and increased apoptosis in TE-1 and Eca-109 cells. Moreover, DDX46 silencing resulted in apoptotic induction via decreased phosphorylation of Akt and IκBα, as well as negative regulation of NF-κB signaling. In conclusion, these results demonstrate that DDX46 knockdown inhibited cell growth, and induced apoptosis, suggest that DDX46 is critical for ESCC cells proliferation. In addition, this study provides a foundation for further study into the clinical potential diagnosis and novel therapeutic target for ESCC.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Chen W, Zheng R, Zeng H, Zhang S and He J: Annual report on status of cancer in China, 2011. Chin J Cancer Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
3	Siewert JR and Ott K: Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol. 17:38–44. 2007. View Article : Google Scholar
4	Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun ZM, Zhang F, Zhao ZR, Li ZT, Liu ZY, et al: Genetic landscape of esophageal squamous cell carcinoma. Nat Genet. 46:1097–1102. 2014. View Article : Google Scholar : PubMed/NCBI
5	Moorcraft SY and Chau I: Investigational therapies targeting the ErbB family in oesophagogastric cancer. Expert Opin Investig Drugs. 23:1349–1363. 2014. View Article : Google Scholar : PubMed/NCBI
6	Jankowsky E: RNA helicases at work: Binding and rearranging. Trends Biochem Sci. 36:19–29. 2011. View Article : Google Scholar :
7	Linder P and Fuller-Pace F: Happy birthday: 25 years of DEAD-box proteins. Methods Mol Biol. 1259:17–33. 2015. View Article : Google Scholar : PubMed/NCBI
8	Fuller-Pace FV: DEAD box RNA helicase functions in cancer. RNA Biol. 10:121–132. 2013. View Article : Google Scholar : PubMed/NCBI
9	Heerma van Voss MR, Vesuna F, Trumpi K, Brilliant J, Berlinicke C, de Leng W, Kranenburg O, Offerhaus GJ, Bürger H, van der Wall E, et al: Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer. Oncotarget. 6:28312–28326. 2015. View Article : Google Scholar : PubMed/NCBI
10	Bol GM, Vesuna F, Xie M, Zeng J, Aziz K, Gandhi N, Levine A, Irving A, Korz D, Tantravedi S, et al: Targeting DDX3 with a small molecule inhibitor for lung cancer therapy. EMBO Mol Med. 7:648–669. 2015. View Article : Google Scholar : PubMed/NCBI
11	Xu YZ and Query CC: Competition between the ATPase Prp5 and branch region-U2 snRNA pairing modulates the fidelity of spliceosome assembly. Mol Cell. 28:838–849. 2007. View Article : Google Scholar : PubMed/NCBI
12	Kosowski TR, Keys HR, Quan TK and Ruby SW: DExD/H-box Prp5 protein is in the spliceosome during most of the splicing cycle. RNA. 15:1345–1362. 2009. View Article : Google Scholar : PubMed/NCBI
13	Hozumi S, Hirabayashi R, Yoshizawa A, Ogata M, Ishitani T, Tsutsumi M, Kuroiwa A, Itoh M and Kikuchi Y: DEAD-box protein Ddx46 is required for the development of the digestive organs and brain in zebrafish. PLoS One. 7:e336752012. View Article : Google Scholar : PubMed/NCBI
14	Hirabayashi R, Hozumi S, Higashijima S and Kikuchi Y: Ddx46 is required for multi-lineage differentiation of hematopoietic stem cells in zebrafish. Stem Cells Dev. 22:2532–2542. 2013. View Article : Google Scholar : PubMed/NCBI
15	Abdelhaleem M, Maltais L and Wain H: The human DDX and DHX gene families of putative RNA helicases. Genomics. 81:618–622. 2003. View Article : Google Scholar : PubMed/NCBI
16	Li M, Ma Y, Huang P, Du A, Yang X, Zhang S, Xing C, Liu F and Cao J: Lentiviral DDX46 knockdown inhibits growth and induces apoptosis in human colorectal cancer cells. Gene. 560:237–244. 2015. View Article : Google Scholar : PubMed/NCBI
17	Linder P, Lasko PF, Ashburner M, Leroy P, Nielsen PJ, Nishi K, Schnier J and Slonimski PP: Birth of the D-E-A-D box. Nature. 337:121–122. 1989. View Article : Google Scholar : PubMed/NCBI
18	Germain DR, Graham K, Glubrecht DD, Hugh JC, Mackey JR and Godbout R: DEAD box 1: A novel and independent prognostic marker for early recurrence in breast cancer. Breast Cancer Res Treat. 127:53–63. 2011. View Article : Google Scholar
19	Lu D and Yunis JJ: Cloning, expression and localization of an RNA helicase gene from a human lymphoid cell line with chromosomal breakpoint 11q23.3. Nucleic Acids Res. 20:1967–1972. 1992. View Article : Google Scholar : PubMed/NCBI
20	Akao Y, Marukawa O, Morikawa H, Nakao K, Kamei M, Hachiya T and Tsujimoto Y: The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues. Cancer Res. 55:3444–3449. 1995.PubMed/NCBI
21	Hashimoto K, Nakagawa Y, Morikawa H, Niki M, Egashira Y, Hirata I, Katsu K and Akao Y: Co-overexpression of DEAD box protein rck/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines. Carcinogenesis. 22:1965–1970. 2001. View Article : Google Scholar : PubMed/NCBI
22	Nakagawa Y, Morikawa H, Hirata I, Shiozaki M, Matsumoto A, Maemura K, Nishikawa T, Niki M, Tanigawa N, Ikegami M, et al: Overexpression of rck/p54, a DEAD box protein, in human colorectal tumours. Br J Cancer. 80:914–917. 1999. View Article : Google Scholar : PubMed/NCBI
23	Miyaji K, Nakagawa Y, Matsumoto K, Yoshida H, Morikawa H, Hongou Y, Arisaka Y, Kojima H, Inoue T, Hirata I, et al: Overexpression of a DEAD box/RNA helicase protein, rck/p54, in human hepatocytes from patients with hepatitis C virus-related chronic hepatitis and its implication in hepatocellular carcinogenesis. J Viral Hepat. 10:241–248. 2003. View Article : Google Scholar : PubMed/NCBI
24	Causevic M, Hislop RG, Kernohan NM, Carey FA, Kay RA, Steele RJ and Fuller-Pace FV: Overexpression and polyubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours. Oncogene. 20:7734–7743. 2001. View Article : Google Scholar : PubMed/NCBI
25	Yang L, Lin C and Liu ZR: Phosphorylations of DEAD box p68 RNA helicase are associated with cancer development and cell proliferation. Mol Cancer Res. 3:355–363. 2005. View Article : Google Scholar : PubMed/NCBI
26	Shin S, Rossow KL, Grande JP and Janknecht R: Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res. 67:7572–7578. 2007. View Article : Google Scholar : PubMed/NCBI
27	Clark EL, Coulson A, Dalgliesh C, Rajan P, Nicol SM, Fleming S, Heer R, Gaughan L, Leung HY, Elliott DJ, et al: The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Res. 68:7938–7946. 2008. View Article : Google Scholar : PubMed/NCBI
28	Wortham NC, Ahamed E, Nicol SM, Thomas RS, Periyasamy M, Jiang J, Ochocka AM, Shousha S, Huson L, Bray SE, et al: The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer. Oncogene. 28:4053–4064. 2009. View Article : Google Scholar : PubMed/NCBI
29	Mazurek A, Luo W, Krasnitz A, Hicks J, Powers RS and Stillman B: DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cells. Cancer Discov. 2:812–825. 2012. View Article : Google Scholar : PubMed/NCBI
30	Wang SJ, Zhang C, You Y and Shi CM: Overexpression of RNA helicase p68 protein in cutaneous squamous cell carcinoma. Clin Exp Dermatol. 37:882–888. 2012. View Article : Google Scholar : PubMed/NCBI
31	Wang R, Jiao Z, Li R, Yue H and Chen L: p68 RNA helicase promotes glioma cell proliferation in vitro and in vivo via direct regulation of NF-κB transcription factor p50. Neuro-oncol. 14:1116–1124. 2012. View Article : Google Scholar
32	Sugiura T, Nagano Y and Noguchi Y: DDX39, upregulated in lung squamous cell cancer, displays RNA helicase activities and promotes cancer cell growth. Cancer Biol Ther. 6:957–964. 2007. View Article : Google Scholar : PubMed/NCBI
33	Kikuta K, Kubota D, Saito T, Orita H, Yoshida A, Tsuda H, Suehara Y, Katai H, Shimada Y, Toyama Y, et al: Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor. J Proteomics. 75:1089–1098. 2012. View Article : Google Scholar
34	Lin F, Wang R, Shen JJ, Wang X, Gao P, Dong K and Zhang HZ: Knockdown of RCK/p54 expression by RNAi inhibits proliferation of human colorectal cancer cells in vitro and in vivo. Cancer Biol Ther. 7:1669–1676. 2008. View Article : Google Scholar : PubMed/NCBI
35	Nicol SM, Bray SE, Black HD, Lorimore SA, Wright EG, Lane DP, Meek DW, Coates PJ and Fuller-Pace FV: The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage. Oncogene. 32:3461–3469. 2013. View Article : Google Scholar
36	Testa JR and Bellacosa A: AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA. 98:10983–10985. 2001. View Article : Google Scholar : PubMed/NCBI
37	Mandal M, Kim S, Younes MN, Jasser SA, El-Naggar AK, Mills GB and Myers JN: The Akt inhibitor KP372–1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells. Br J Cancer. 92:1899–1905. 2005. View Article : Google Scholar : PubMed/NCBI
38	Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI